secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2026-03-12T23:59:59+00:00
Accession:  0001193125-26-104291
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.08, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics sets 2026 annual meeting for May 14; proxy deadlines March 22
-------------------------------------------------------------------------------

- Annual meeting scheduled for May 14, 2026 at 9:00 a.m. ET, held virtually.
- Record date for stockholders is March 18, 2026.
- Deadline for Rule 14a-8 stockholder proposals and director nominations: March 22, 2026.
- Meeting date is more than 30 days before 2025 anniversary, rendering prior proxy deadlines void.
- Universal proxy rule compliance notice also due by March 22, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312526104291/0001193125-26-104291-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312526104291/pstv-20260311.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-104291

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer